1. Thirteen-year experience in lung transplantation for emphysema
Stephen D Cassivi, MD, Bryan F Meyers, MD, Richard J Battafarano, MD, Tracey J Guthrie, RN, Elbert P Trulock, MD, John P Lynch, MD, Joel D Cooper, MD, G.Alexander Patterson, MD 
The Annals of Thoracic Surgery 
Volume 74, Issue 5, Pages (November 2002)
DOI: /S (02)04064-X

2. Fig 1
Lung transplants performed for alpha1 antitrypsin deficiency (Alpha-1), chronic obstructive pulmonary disease (COPD), and all other diagnoses at Washington University in St. Louis by year.
The Annals of Thoracic Surgery  , DOI: ( /S (02)04064-X)

3. Fig 2
Lung transplant actuarial survival by diagnosis. (Alpha-1 = alpha1 antitrypsin deficiency; COPD = chronic obstructive pulmonary disease; Other = lung transplant recipients with other diagnoses.)
The Annals of Thoracic Surgery  , DOI: ( /S (02)04064-X)

4. Fig 3
Actuarial survival of lung transplantation for emphysema by type of procedure (single vs bilateral lung transplantation).
The Annals of Thoracic Surgery  , DOI: ( /S (02)04064-X)

5. Fig 4
Actuarial survival of lung transplantation for emphysema by era (1988 to 1994, 1995 to 2000).
The Annals of Thoracic Surgery  , DOI: ( /S (02)04064-X)

6. Fig 5
Freedom from bronchiolitis obliterans by diagnosis. (Alpha-1 = alpha1 antitrypsin deficiency; COPD = chronic obstructive pulmonary disease.)
The Annals of Thoracic Surgery  , DOI: ( /S (02)04064-X)

7. Fig 6
Freedom from bronchiolitis obliterans by type of procedure (single vs bilateral lung transplantation).
The Annals of Thoracic Surgery  , DOI: ( /S (02)04064-X)